Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4813)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2021 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li XY, Guan QX, Shang YZ, Wang YH, Lv SW, Yang ZX, Wang R, Feng YF, Li WN, Li YJ. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 2021; 27(26): 4208-4220 [PMID: 34326620 DOI: 10.3748/wjg.v27.i26.4208] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i26/4208.htm |
| Number | Citing Articles |
| 1 |
Wei Cao, Zezhi Lin, Daoyi Zheng, Jianjun Zhang, Weili Heng, Yuanfeng Wei, Yuan Gao, Shuai Qian. Metal–organic gels: recent advances in their classification, characterization, and application in the pharmaceutical field. Journal of Materials Chemistry B 2023; 11(44): 10566 doi: 10.1039/D3TB01612A
|
| 2 |
QingXia Guan, XiaoYing Zhou, FangFang Yang, Xue Zhang, YanHong Wang, WeiNan Li, XiuYan Li. A novel strategy against hepatitis B virus: Glycyrrhetnic acid conjugated multi-component synergistic nano-drug delivery system for targeted therapy. Journal of Biomaterials Applications 2023; 37(8): 1393 doi: 10.1177/08853282221139132
|
| 3 |
Bing-Tao Zhai, Jing Sun, Ya-Jun Shi, Xiao-Fei Zhang, Jun-Bo Zou, Jiang-Xue Cheng, Yu Fan, Dong-Yan Guo, Huan Tian. Review targeted drug delivery systems for norcantharidin in cancer therapy. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01703-3
|
| 4 |
Wang Sun, Xianhui Zhao, Erin Webb, Gang Xu, Weijie Zhang, Yang Wang. Advances in metal–organic framework-based hydrogel materials: preparation, properties and applications. Journal of Materials Chemistry A 2023; 11(5): 2092 doi: 10.1039/D2TA08841J
|
| 5 |
Zi-Jun Yan, Xiao-Ping Wu, Pan-Pan Wei, Meng-Yue Deng, Kun Yang, Liang-Ming Zhang, Yu-Zhen Ding, Die Xia, Bing-Suo Ma, Lei Zhang, Xiao-Yan Yuan, Tong Chen. Effective Platform for Enhancing the Bioavailability and Anti-Cancer Efficacy of Norcantharidin: Nanoemulsion Hybrid Lipid Carriers. Journal of Biomedical Nanotechnology 2023; 19(4): 527 doi: 10.1166/jbn.2023.3574
|
| 6 |
Susu Xiao, Yu Wang, Wenqiong Ma, Ping Zhou, Biqiong Wang, Zhouxue Wu, Qian Wen, Kang Xiong, Yanlin Liu, Shaozhi Fu. Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma. Drug Delivery 2022; 29(1): 2713 doi: 10.1080/10717544.2022.2111480
|
| 7 |
Dongge Yin, Xueling Hu, Mengru Cai, Kaixin Wang, Hulinyue Peng, Jie Bai, Yvchen Xv, Tingting Fu, Xiaoxv Dong, Jian Ni, Xingbin Yin. Preparation, Characterization, and In Vitro Release of Curcumin-Loaded IRMOF-10 Nanoparticles and Investigation of Their Pro-Apoptotic Effects on Human Hepatoma HepG2 Cells. Molecules 2022; 27(12): 3940 doi: 10.3390/molecules27123940
|
| 8 |
Zijun Yan, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao, Tong Chen, Fu Wang. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/3851604
|
| 9 |
Miaodong Wang, Peichun Peng, Zeshan Chen, Xin Deng. Nanoparticle Delivery of Active Traditional Chinese Medicine Ingredients:
A New Strategy for the Treatment of Liver Cancer. Current Pharmaceutical Biotechnology 2023; 24(13): 1630 doi: 10.2174/1389201024666230313151316
|
| 10 |
Qian Liu, Henglai Sun, Xinyu Li, Huagang Sheng, Liqiao Zhu. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Molecules 2022; 27(22): 7740 doi: 10.3390/molecules27227740
|
| 11 |
Yifan Liu, Yushan Liang, Jing Yuhong, Peng Xin, Jia Li Han, Yongle Du, Xinru Yu, Runhe Zhu, Mingxun Zhang, Wen Chen, Yingjie Ma. Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. Drug Design, Development and Therapy 2024; : 1469 doi: 10.2147/DDDT.S447496
|
| 12 |
Gorka Calvo-Martín, Daniel Plano, Nuria Martínez-Sáez, Carlos Aydillo, Esther Moreno, Socorro Espuelas, Carmen Sanmartín. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments. Pharmaceuticals 2022; 15(12): 1465 doi: 10.3390/ph15121465
|
| 13 |
Daixia Huo, Qiuxu An, Mingzhe Li, Xiaojie Lv. Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment. Microporous and Mesoporous Materials 2024; 369: 113013 doi: 10.1016/j.micromeso.2024.113013
|
| 14 |
Jing Wang, Gang Chen, Xue Yang, Wenwen Dou, Yuhang Mao, Yudie Zhang, Xiaotian Shi, Yehua Xia, Qiuyi You, Mei Liu. Inhibitory effects of norcantharidin on titanium particle-induced osteolysis, osteoclast activation and bone resorption via MAPK pathways. International Immunopharmacology 2024; 129: 111655 doi: 10.1016/j.intimp.2024.111655
|